Dataset Information

Laser-assisted rapid evaporative ionisation mass spectrometry (LA-REIMS) as a metabolomics platform in cervical cancer screening

ABSTRACT:

BACKGROUND: The introduction of high-risk human papillomavirus (hrHPV) testing as part of primary cervical screening is anticipated to improve sensitivity, but also the number of women who will screen positive. Reflex cytology is the preferred triage test in most settings but has limitations including moderate diagnostic accuracy, lack of automation, inter-observer variability and the need for clinician-collected sample. Novel, objective and cost-effective approaches are needed.

METHODS: In this study, we assessed the potential use of an automated metabolomic robotic platform, employing the principle of laser-assisted Rapid Evaporative Ionisation Mass Spectrometry (LA-REIMS) in cervical cancer screening.

FINDINGS: In a population of 130 women, LA-REIMS achieved 94% sensitivity and 83% specificity (AUC: 91.6%) in distinguishing women testing positive (n = 65) or negative (n = 65) for hrHPV. We performed further analysis according to disease severity with LA-REIMS achieving sensitivity and specificity of 91% and 73% respectively (AUC: 86.7%) in discriminating normal from high-grade pre-invasive disease.

INTERPRETATION: This automated high-throughput technology holds promise as a low-cost and rapid test for cervical cancer screening and triage. The use of platforms like LA-REIMS has the potential to further improve the accuracy and efficiency of the current national screening programme.

FUNDING: Work was funded by the MRC Imperial Confidence in Concept Scheme, Imperial College Healthcare Charity, British Society for Colposcopy and Cervical Pathology, National Research Development and Innovation Office of Hungary, Waters corporation and NIHR BRC.

INSTRUMENT(S): Direct infusion MS - negative

SUBMITTER: Simon Cameron

PROVIDER: MTBLS1371 | MetaboLights | 2022-02-15

REPOSITORIES: MetaboLights

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	MTBLS1371	Other
	FILES	Other
	a_MTBLS1371_DI-MS_negative__metabolite_profiling.txt	Txt
	i_Investigation.txt	Txt
	m_MTBLS1371_DI-MS_negative__metabolite_profiling_v2_maf.tsv	Tabular

Items per page:

1 - 5 of 6

Publications

Laser-assisted rapid evaporative ionisation mass spectrometry (LA-REIMS) as a metabolomics platform in cervical cancer screening.

Paraskevaidi Maria M Cameron Simon J S SJS Whelan Eilbhe E Bowden Sarah S Tzafetas Menelaos M Mitra Anita A Semertzidou Anita A Athanasiou Antonis A Bennett Phillip R PR MacIntyre David A DA Takats Zoltan Z Kyrgiou Maria M

EBioMedicine 20200925

<h4>Background</h4>The introduction of high-risk human papillomavirus (hrHPV) testing as part of primary cervical screening is anticipated to improve sensitivity, but also the number of women who will screen positive. Reflex cytology is the preferred triage test in most settings but has limitations including moderate diagnostic accuracy, lack of automation, inter-observer variability and the need for clinician-collected sample. Novel, objective and cost-effective approaches are needed.<h4>Method ...[more]

PMID: 32980699

Similar Datasets

Project description:<h4><strong>BACKGROUND: </strong>Palmar osteochondral disease (POD) is a common cause of lameness in competition horses. Magnetic resonance imaging (MRI) is the most sensitive diagnostic modality currently available, however it may not be financially or logistically practical for routine screening of POD. There is increasing interest in the use of metabolomics for diagnosis prior to progression to irreversible damage.</h4><h4><strong>OBJECTIVES: </strong>To determine metabolite levels in synovial fluid (SF) of horses with a clinical diagnosis of POD based on diagnostic analgesia and MRI, with the hypothesis that metabolomic profiles differ between diseased and healthy joints.</h4><h4><strong>STUDY DESIGN:</strong> Prospective clinical study.</h4><h4><strong>METHODS: </strong>Synovial fluid was collected from metacarpo/tarsophalangeal joints (MC/TPJ) of 29 horses (n = 51 joints), including 14 controls (n = 26) and 15 cases (n = 25), the latter with lameness localised to the MC/TPJ and MR changes consistent with POD (n = 23). Spectra were produced using <sup>1</sup> H-nuclear magnetic resonance (NMR) spectroscopy and analysed.</h4><h4><strong>RESULTS: </strong>Twenty-five metabolites were recognised associated with various biosynthetic and degradation pathways. The metabolite abundances within the controls demonstrated increased variability compared with the clinical group. The low level of variance between the spectra of the two groups was explained by five principal components. Cross-validation of the cohort demonstrated modest separation of predictive power (R<sup>2</sup> = 0.67; Q<sup>2</sup> = 0.34). Although statistical significance was not achieved, the most influential metabolites were glucose and lactate.</h4><h4><strong>MAIN LIMITATIONS:</strong> The modest sample size and variation in signalment, background and presenting condition of the controls may have impacted the discriminative power of the constructed models. The lack of matched controls, differences in time of fluid collection and freezing times may have also reduced accuracy when representing metabolite profiles.</h4><h4><strong>CONCLUSIONS:</strong> This study identified and quantified metabolites present in MC/TPJ SF of clinical cases with POD.</h4>